Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer

NCT07669467 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Fatigue Related to Cancer Treatment
Breast Cancer

Interventions

DRUG: Nuvastatic 300
DRUG: Placebo

Sponsor

Natureceuticals Sdn Bhd